Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)

Clinical trial NCT05354141 · RECRUITING

Trial details

NCT number: NCT05354141
Sponsor: Direct Biologics, LLC
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Respiratory Distress Syndrome ARDS

Start date: 2022-07-01
Primary completion: 2027-11-30
Enrollment: 970

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.